BSE demat auction settlement no. 764 listing securities and quantities available for auction on November 27, 2025.
Impact
Low
Severity
Low
Justification
Routine demat auction notice affecting specific scrips with limited market-wide impact; relevant only to brokers and investors holding these securities in demat form
List of securities under demat auction for settlement number 764 dated November 27, 2025, containing 108 scrips with their respective quantities.
Impact
Medium
Severity
Medium
Justification
Demat auction affects 108 securities including major blue-chip stocks, impacting settlement obligations for brokers and investors with pending deliveries.
BSE demat auction settlement listing securities from various companies including Adani Energy, Bajaj Auto, Infosys, Tata Steel and others for settlement number 764.
Impact
Low
Severity
Low
Justification
Routine demat auction settlement affecting limited quantities of various securities. Standard market operation with minimal market-wide impact.
BSE demat auction settlement listing securities and quantities for settlement number 764.
Impact
Low
Severity
Low
Justification
Routine demat auction settlement listing specific securities and quantities for auction participants. This is a regular operational activity with limited market-wide impact.
Novelix Pharmaceuticals Limited lists 15,45,000 new equity shares issued at Rs. 20/- on preferential basis pursuant to warrant conversion, with lock-in periods up to June 2027.
Impact
Low
Severity
Low
Justification
Routine listing of preferential shares from warrant conversion affecting a single small-cap company with limited market impact
15,45,000 equity shares of Novelix Pharmaceuticals Limited (Scrip Code 536565) issued at Rs. 20/- on preferential basis pursuant to warrant conversion, listed and permitted to trade from November 27, 2025.
Impact
Low
Severity
Low
Justification
Routine listing notice for preferential allotment of shares pursuant to warrant conversion. Limited market impact as it affects a single company's expanded share capital with lock-in restrictions.
Novelix Pharmaceuticals Limited lists 15,45,000 equity shares issued at Rs. 20/- on preferential basis pursuant to conversion of warrants, with lock-in periods until June 2026 and 2027.
Impact
Low
Severity
Low
Justification
Routine listing of preferential allotment shares from warrant conversion for a single company with modest share count and lock-in restrictions.
BSE announces demat auction for settlement number 747 covering 118 scrips with pending delivery obligations across various quantities.
Impact
Medium
Severity
Medium
Justification
Regular demat auction process affecting 118 scrips with varying quantities; impacts brokers and clients with pending delivery obligations but is a standard settlement mechanism
BSE announces demat auction settlement 747 covering 118 scrips with specified quantities for settlement dated November 3, 2025.
Impact
Medium
Severity
Medium
Justification
Routine demat auction settlement affecting 118 scrips with varying quantities. Important for specific brokers/clients with delivery obligations but not market-wide impact.